Leslee J. Shaw et al. JIMG 2010;3:

Slides:



Advertisements
Similar presentations
Clinical Trials. Date & location – January-November 1998, stress SPECT patients randomly received tetrofosmin or sestamibi (n~1550) Inclusion criteria.
Advertisements

Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiovascular Imaging Research at the Crossroads.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: When to stress patients after coronary artery bypass.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Outcomes and Cost-Effectiveness of Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Procedural Outcomes of Chronic Total Occlusion Percutaneous.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
(CCTA, computed coronary tomography angiography; CMR, cardiac magnetic resonance; ECG, electrocardiogram; Echo, echocardiography; IHD, ischemic heart disease;
From: Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of.
Copyright © 2005 American Medical Association. All rights reserved.
Successful CTO PCI Associated with Lower Mortality Risk
Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.
Glenn N. Levine et al. JACC 2016;68:
Zhi-hui Hou et al. JIMG 2012;5:
Tareq Ibrahim et al. JIMG 2009;2:
Glenn N. Levine et al. JACC 2016;68:
Manuel Caceres, MD, Darryl S. Weiman, MD, JD 
Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A
European Society of Cardiology 2003
Nat. Rev. Cardiol. doi: /nrcardio
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients  Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.
Defining operative mortality: Impact on outcome reporting
Why surgery won the SYNTAX trial and why it matters
Coronary revascularisation rate (total 5
Category: PCI Research
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.
Clinical course of participants with high cardiovascular risk profile
For everything there is a season
(A) Meta-analysis of repeat revascularisation in randomised trials.
(A) Multivariable Cox regressions showing the association of higher CHA2DS2-Vasc scores (≥6) and (B) R2CHA2DS2-Vasc scores (≥7) with 1-year mortality (CABG,
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome (CABG-ACS) trial. Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome.
Nicole M. Bhave et al. JIMG 2018;11:
Nicole M. Bhave et al. JIMG 2018;11:
Nicole M. Bhave et al. JIMG 2018;11:
Glenn N. Levine et al. JACC 2011;58:e44-e122
Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.
Alan Rozanski et al. JIMG 2017;10:
Lee A. Fleisher et al. JACC 2014;64:e77-e137
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Davide Capodanno et al. JCIN 2009;2:
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Federico Migliore et al. JIMG 2013;6:32-41
J. Wells Askew et al. JIMG 2009;2:
Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test
Victor A. Ferrari et al. JIMG 2014;7:
Leslee J. Shaw et al. JIMG 2010;3:
Federico Migliore et al. JIMG 2013;6:32-41
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Federico Migliore et al. JIMG 2013;6:32-41
Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

Leslee J. Shaw et al. JIMG 2010;3:316-324 Data Linkages to Facilitate Cost and Clinical Outcome Assessment CathPCI is a data registry within the American College of Cardiology's National Cardiovascular Data Registry. ACS = acute coronary syndrome; AMI = acute myocardial infarction; CABG = coronary artery bypass graft; CCTA = coronary computed tomographic angiography; CV = cardiovascular; Echo = echocardiography; IC3 = Improving Continuous Cardiac Care; MPI = myocardial perfusion imaging; NCHS NDI = National Center for Health Statistics National Death Index; PCI = percutaneous coronary intervention. Leslee J. Shaw et al. JIMG 2010;3:316-324 American College of Cardiology Foundation

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.